{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:29:34Z","timestamp":1786580974532,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":142,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP. 2\/233\/46"],"award-info":[{"award-number":["RGP. 2\/233\/46"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42545-5","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:29:41Z","timestamp":1774355381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["pH-responsive acetylated PAMAM dendrimer nanocarriers for enhanced intravesical delivery of Erdafitinib in urothelial carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Gowdru Vishwanath","family":"Nahusha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8280-6443","authenticated-orcid":false,"given":"Venkatesh Dinnekere","family":"Puttegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rahamathulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ghazwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joysa Ruby","family":"J","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya Khader Ahmad","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Ayesha","family":"Farhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunatha P.","family":"Mudaghal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Muqtader","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2579-4032","authenticated-orcid":false,"given":"Ismail","family":"Pasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"3","key":"42545_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 74(3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA. Cancer J. Clin."},{"issue":"19","key":"42545_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196608","volume":"27","author":"SA Mir","year":"2022","unstructured":"Mir, S. A. et al. Role of nanotechnology in overcoming the multidrug resistance in cancer therapy: A review. Molecules 27(19), 6608. https:\/\/doi.org\/10.3390\/molecules27196608 (2022).","journal-title":"Molecules"},{"issue":"2","key":"42545_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jsps.2022.12.008","volume":"31","author":"Y Alhamhoom","year":"2023","unstructured":"Alhamhoom, Y. et al. Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review. Saudi Pharm. J. 31(2), 279\u2013294. https:\/\/doi.org\/10.1016\/j.jsps.2022.12.008 (2023).","journal-title":"Saudi Pharm. J."},{"issue":"7","key":"42545_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1158\/2159-8290.CD-24-0128","volume":"14","author":"W Hill","year":"2024","unstructured":"Hill, W., Weeden, C. E. & Swanton, C. Tumor promoters and opportunities for molecular cancer prevention. Cancer Discov. 14(7), 1154\u20131160. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0128 (2024).","journal-title":"Cancer Discov."},{"issue":"26","key":"42545_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202312169","volume":"36","author":"T Lammers","year":"2024","unstructured":"Lammers, T. Nanomedicine tumor targeting. Adv. Mater. 36(26), e2312169. https:\/\/doi.org\/10.1002\/adma.202312169 (2024).","journal-title":"Adv. Mater."},{"issue":"7","key":"42545_CR6","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho, A. M. et al. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int. J. Cancer. 156(7), 1336\u20131346. https:\/\/doi.org\/10.1002\/ijc.35278 (2025).","journal-title":"Int. J. Cancer."},{"issue":"5","key":"42545_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LM van Hoogstraten","year":"2023","unstructured":"van Hoogstraten, L. M. et al. Global trends in the epidemiology of bladder cancer: Challenges for public health and clinical practice. Nat. Rev. Clin. Oncol. 20(5), 287\u2013304. https:\/\/doi.org\/10.1038\/s41571-023-00744-3 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"42545_CR8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27330","author":"SA Halaseh","year":"2022","unstructured":"Halaseh, S. A., Halaseh, S., Alali, Y., Ashour, M. E. & Alharayzah, M. J. A review of the etiology and epidemiology of bladder cancer: all you need to know. Cureus https:\/\/doi.org\/10.7759\/cureus.27330 (2022).","journal-title":"Cureus"},{"issue":"5","key":"42545_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/ajhp\/zxz329","volume":"77","author":"K Roubal","year":"2020","unstructured":"Roubal, K., Myint, Z. W. & Kolesar, J. M. Erdafitinib: A novel therapy for FGFR-mutated urothelial cancer. Am. J. Health Syst. Pharm. 77(5), 346\u201351. https:\/\/doi.org\/10.1093\/ajhp\/zxz329 (2020).","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"8","key":"42545_CR10","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/S1470-2045(24)00134-7","volume":"25","author":"CJPO\u2019 Hoog","year":"2024","unstructured":"Hoog, C. J. P. O. \u2019 et al. Dose selection of novel anticancer drugs: Exposing the gap between selected and required doses. Lancet Oncol. 25(8), e340\u2013e351. https:\/\/doi.org\/10.1016\/S1470-2045(24)00134-7 (2024).","journal-title":"Lancet Oncol."},{"issue":"4","key":"42545_CR11","first-page":"145","volume":"21","author":"V Golla","year":"2019","unstructured":"Golla, V., Lenis, A. T., Faiena, I. & Chamie, K. Intravesical therapy for non-muscle invasive bladder cancer-current and future options in the age of Bacillus Calmette-Guerin shortage. Rev. Urol. 21(4), 145\u2013153 (2019).","journal-title":"Rev. Urol."},{"issue":"1","key":"42545_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/13696998.2023.2189860","volume":"26","author":"K Grabe-Heyne","year":"2023","unstructured":"Grabe-Heyne, K. et al. Evaluating the cost-utility of intravesical Bacillus Calmette-Gu\u00e9rin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK. J. Med. Econ. 26(1), 411\u2013421. https:\/\/doi.org\/10.1080\/13696998.2023.2189860 (2023).","journal-title":"J. Med. Econ."},{"key":"42545_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100353","volume":"10","author":"S Imani","year":"2025","unstructured":"Imani, S. et al. Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances. Int. J. Pharm. X 10, 100353. https:\/\/doi.org\/10.1016\/j.ijpx.2025.100353 (2025).","journal-title":"Int. J. Pharm. X"},{"issue":"12","key":"42545_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16121582","volume":"16","author":"C Feng","year":"2024","unstructured":"Feng, C. et al. Precisely tailoring molecular structure of doxorubicin prodrugs to enable stable nanoassembly, rapid activation, and potent antitumor effect. Pharmaceutics 16(12), 1582. https:\/\/doi.org\/10.3390\/pharmaceutics16121582 (2024).","journal-title":"Pharmaceutics"},{"issue":"8","key":"42545_CR15","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s44211-025-00799-5","volume":"41","author":"Z Khan","year":"2025","unstructured":"Khan, Z. et al. Therapeutic applications of nanobots and nanocarriers in cancer treatment. Anal. Sci. 41(8), 1305\u20131324. https:\/\/doi.org\/10.1007\/s44211-025-00799-5 (2025).","journal-title":"Anal. Sci."},{"issue":"9","key":"42545_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.108192","volume":"34","author":"L Dong","year":"2023","unstructured":"Dong, L. et al. Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy. Chin. Chem. Lett. 34(9), 108192. https:\/\/doi.org\/10.1016\/j.cclet.2023.108192 (2023).","journal-title":"Chin. Chem. Lett."},{"key":"42545_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081576","volume":"14","author":"U Hani","year":"2022","unstructured":"Hani, U. et al. Novel drug delivery systems as an emerging platform for stomach cancer therapy. Pharmaceutics 14, 1576. https:\/\/doi.org\/10.3390\/pharmaceutics14081576 (2022).","journal-title":"Pharmaceutics"},{"issue":"1","key":"42545_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82074-7","volume":"15","author":"A Aghanejad","year":"2025","unstructured":"Aghanejad, A. et al. Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer. Sci. Rep. 15(1), 1813. https:\/\/doi.org\/10.1038\/s41598-024-82074-7 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"42545_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep23179","volume":"6","author":"H Kulhari","year":"2016","unstructured":"Kulhari, H. et al. Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer. Sci. Rep. 6(1), 23179. https:\/\/doi.org\/10.1038\/srep23179 (2016).","journal-title":"Sci. Rep."},{"issue":"14","key":"42545_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/polym16142022","volume":"16","author":"X Yan","year":"2024","unstructured":"Yan, X. & Chen, Q. Polyamidoamine dendrimers: Brain-targeted drug delivery systems in glioma therapy. Polymers 16(14), 2022. https:\/\/doi.org\/10.3390\/polym16142022 (2024).","journal-title":"Polymers"},{"issue":"1","key":"42545_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99004-w","volume":"15","author":"P Jaroniek","year":"2025","unstructured":"Jaroniek, P., Brzezi\u0144ski, M., Chmiela, M. & Gonciarz, W. Doxorubicin loaded polylactide nanoparticles functionalized histamine promote apoptosis of human gastric cancer cells AGS. Sci. Rep. 15(1), 14243. https:\/\/doi.org\/10.1038\/s41598-025-99004-w (2025).","journal-title":"Sci. Rep."},{"issue":"12","key":"42545_CR22","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1016\/j.actbio.2012.07.031","volume":"8","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. Reducing cytotoxicity while improving anti-cancer drug loading capacity of polypropylenimine dendrimers by surface acetylation. Acta Biomater. 8(12), 4304\u201313. https:\/\/doi.org\/10.1016\/j.actbio.2012.07.031 (2012).","journal-title":"Acta Biomater."},{"key":"42545_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s10637-017-0514-4","volume":"36","author":"T Nishina","year":"2018","unstructured":"Nishina, T. et al. Safety, pharmacokinetic, and pharmacodynamics of Erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors. Invest. New Drugs 36, 424\u201334. https:\/\/doi.org\/10.1007\/s10637-017-0514-4 (2018).","journal-title":"Invest. New Drugs"},{"issue":"19","key":"42545_CR24","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2217\/fon-2021-1151","volume":"18","author":"A Franza","year":"2022","unstructured":"Franza, A., Pirovano, M., Giannatempo, P. & Cosmai, L. Erdafitinib in locally advanced\/metastatic urothelial carcinoma with certain FGFR genetic alterations. Future Oncol. 18 (19), 2455\u20132464. https:\/\/doi.org\/10.2217\/fon-2021-1151 (2022).","journal-title":"Future Oncol."},{"issue":"2","key":"42545_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eururo.2024.09.012","volume":"87","author":"R Li","year":"2025","unstructured":"Li, R. et al. FGFR inhibition in urothelial carcinoma. Eur. Urol. 87(2), 110\u2013122. https:\/\/doi.org\/10.1016\/j.eururo.2024.09.012 (2025).","journal-title":"Eur. Urol."},{"key":"42545_CR26","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S466042","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Tumor Cell-Targeting and Tumor Microenvironment-Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic\/Photothermal\/Chemodynamic Treatment of Cervical Cancer. Int. J. Nanomed. 19, 5837\u20135858. https:\/\/doi.org\/10.2147\/IJN.S466042 (2024). Published 2024 Jun 13.","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"42545_CR27","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s11095-024-03747-6","volume":"41","author":"C Romani","year":"2024","unstructured":"Romani, C., Sponchioni, M. & Volonterio, A. Fluorinated PAMAM-Arginine carrier prodrugs for pH-sensitive sustained Ibuprofen delivery. Pharm. Res. 41(8), 1725\u20131736. https:\/\/doi.org\/10.1007\/s11095-024-03747-6 (2024).","journal-title":"Pharm. Res."},{"key":"42545_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2022.107432","volume":"179","author":"T Elawady","year":"2022","unstructured":"Elawady, T., Khedr, A., Nahed, E.-E. & Belal, F. Study of Erdafitinib stress degradation behavior using HPLC-UV analysis and multistage fragmentation ion trap mass spectrometry. Microchem. J. 179, 107432. https:\/\/doi.org\/10.1016\/j.microc.2022.107432 (2022).","journal-title":"Microchem. J."},{"issue":"1","key":"42545_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1248\/cpb.59.63","volume":"59","author":"D Liu","year":"2011","unstructured":"Liu, D. et al. Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells. Chem. Pharm. Bull. (Tokyo) 59(1), 63\u201371. https:\/\/doi.org\/10.1248\/cpb.59.63 (2011).","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"4","key":"42545_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.15171\/apb.2019.070","volume":"9","author":"I Kuncahyo","year":"2019","unstructured":"Kuncahyo, I., Choiri, S., Fudholi, A., Martien, R. & Rohman, A. Assessment of fractional factorial design for the selection and screening of appropriate components of a self-nanoemulsifying drug delivery system formulation. Adv. Pharm. Bull. 9(4), 609\u2013618. https:\/\/doi.org\/10.15171\/apb.2019.070 (2019).","journal-title":"Adv. Pharm. Bull."},{"key":"42545_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110176","volume":"762","author":"AH Mezher","year":"2024","unstructured":"Mezher, A. H., Salehpour, M. & Saadati, Z. Folic acid-functionalized and acetyl-terminated dendrimers as nanovectors for co-delivery of sorafenib and 5-fluorouracil. Arch. Biochem. Biophys. 762, 110176. https:\/\/doi.org\/10.1016\/j.abb.2024.110176 (2024).","journal-title":"Arch. Biochem. Biophys."},{"key":"42545_CR32","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.2147\/IJN.S140111","volume":"12","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation. Int. J. Nanomedicine 12, 7365\u20137374. https:\/\/doi.org\/10.2147\/IJN.S140111 (2017).","journal-title":"Int. J. Nanomedicine"},{"issue":"23","key":"42545_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312614","volume":"25","author":"P Padnya","year":"2024","unstructured":"Padnya, P. et al. Non-viral systems based on PAMAM-Calix-dendrimers for regulatory siRNA delivery into cancer cells. Int. J. Mol. Sci. 25(23), 12614. https:\/\/doi.org\/10.3390\/ijms252312614 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"42545_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2217\/nnm-2023-0355","volume":"19","author":"N Milivojevi\u0107","year":"2024","unstructured":"Milivojevi\u0107, N. et al. Evaluation of novel dendrimer\u2013gold complex nanoparticles for theranostic application in oncology. Nanomedicine 19(6), 483\u201397. https:\/\/doi.org\/10.2217\/nnm-2023-0355 (2024).","journal-title":"Nanomedicine"},{"issue":"8","key":"42545_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28872","volume":"10","author":"OL Ugorji","year":"2024","unstructured":"Ugorji, O. L., Onyishi, I. V., Chukwu, A. & Attama, A. A. Engineering 5-flourouracil and leucovorin-loaded vesicular systems for possible colon specific delivery: In vitro evaluation and real time cell assay against HCT-116 colon cell lines. Heliyon 10(8), e28872. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28872 (2024).","journal-title":"Heliyon"},{"issue":"4","key":"42545_CR36","first-page":"289","volume":"3","author":"P Singh","year":"2013","unstructured":"Singh, P. & Sinha, M. Determination of residual solvents in bulk drug and formulations. Am. J. PharmTech Res. 3 (4), 289\u2013295 (2013).","journal-title":"Am. J. PharmTech Res."},{"issue":"Pt 1","key":"42545_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127564","volume":"257","author":"P Soltany","year":"2024","unstructured":"Soltany, P., Miralinaghi, M. & Pajoum Shariati, F. Folic acid conjugated poly (Amidoamine) dendrimer grafted magnetic chitosan as a smart drug delivery platform for doxorubicin: In-vitro drug release and cytotoxicity studies. Int. J. Biol. Macromol. 257(Pt 1), 127564. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127564 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"42545_CR38","doi-asserted-by":"publisher","first-page":"12075","DOI":"10.2147\/IJN.S541332","volume":"20","author":"S Das","year":"2025","unstructured":"Das, S. et al. Design and optimization of trastuzumab-functionalized nanolipid carriers for targeted capecitabine delivery: Anti-cancer effectiveness evaluation in MCF-7 and SKBR3 cells. Int. J. Nanomedicine 20, 12075\u201312102 (2025).","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"42545_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-14704-7","volume":"15","author":"M Kaveh Zenjanab","year":"2025","unstructured":"Kaveh Zenjanab, M., Salemi, A., Doustmihan, A., Alimohammadvand, S. & Jahanban Esfahlan, R. Dual-loaded niosome-dendrimer nanoplatform enhances Tirapazamine delivery to hypoxic breast cancer cells. Sci. Rep. 15(1), 29308. https:\/\/doi.org\/10.1038\/s41598-025-14704-7 (2025).","journal-title":"Sci. Rep."},{"key":"42545_CR40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.22214\/ijraset.2019.12163","volume":"7","author":"MA Pawar","year":"2019","unstructured":"Pawar, M. A. & Khandelwal, M. H. An overview-International Conference on Harmonisation and ICH (Q1) stability testing guideline for pharmaceutical development. Int. J. Res. Appl. Sci. Eng. Technol. 7, 1042\u201352 (2019).","journal-title":"Int. J. Res. Appl. Sci. Eng. Technol."},{"key":"42545_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-26145-3","volume":"15","author":"S Fathi-karkan","year":"2025","unstructured":"Fathi-karkan, S., Rahdar, A. & Shirzad, M. Integrating machine-learning and nanotechnology to quantify pH-modulated oxaliplatin release. Sci. Rep. 15, 42190. https:\/\/doi.org\/10.1038\/s41598-025-26145-3 (2025).","journal-title":"Sci. Rep."},{"key":"42545_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113499","volume":"220","author":"K Ran","year":"2021","unstructured":"Ran, K. et al. Design, synthesis and biological evaluations of a series of Pyrido[1,2-a]pyrimidinone derivatives as novel selective FGFR inhibitors. Eur. J. Med. Chem. 220, 113499. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113499 (2021).","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"42545_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2024.130751","volume":"1869","author":"M Amir","year":"2025","unstructured":"Amir, M., Qureshi, M. A., Musarrat, J. & Javed, S. Structural investigation of Erdafitinib, an anticancer drug, with ctDNA: A spectroscopic and computational study. Biochimica et Biophysica Acta (BBA) - General Subjects 1869(2), 130751. https:\/\/doi.org\/10.1016\/j.bbagen.2024.130751 (2025).","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"42545_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejps.2018.07.020","volume":"122","author":"M Ghaffari","year":"2018","unstructured":"Ghaffari, M. et al. Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting. Eur. J. Pharm. Sci. 122, 311\u201330. https:\/\/doi.org\/10.1016\/j.ejps.2018.07.020 (2018).","journal-title":"Eur. J. Pharm. Sci."},{"key":"42545_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep14986","volume":"5","author":"S Misra","year":"2015","unstructured":"Misra, S. et al. Regulating biocompatibility of carbon spheres via defined nanoscale chemistry and a careful selection of surface functionalities. Sci. Rep. 5, 14986. https:\/\/doi.org\/10.1038\/srep14986 (2015).","journal-title":"Sci. Rep."},{"key":"42545_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep33844","volume":"6","author":"R Wang","year":"2016","unstructured":"Wang, R. et al. Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT\/MR dual-mode imaging of hepatocellular carcinoma. Sci. Rep. 6, 33844. https:\/\/doi.org\/10.1038\/srep33844 (2016).","journal-title":"Sci. Rep."},{"key":"42545_CR47","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s13346-017-0373-8","volume":"7","author":"C Yan","year":"2017","unstructured":"Yan, C., Gu, J., Lv, Y., Shi, W. & Jing, H. Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat. Drug. Deliv. Transl. Res. 7, 408\u201315. https:\/\/doi.org\/10.1007\/s13346-017-0373-8 (2017).","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"7","key":"42545_CR48","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/0008-5472.CAN-21-2897","volume":"82","author":"V Bellat","year":"2022","unstructured":"Bellat, V. et al. A urinary drug-disposing approach as an alternative to intravesical chemotherapy for treating nonmuscle invasive bladder cancer. Cancer Res. 82(7), 1409\u20131422. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-2897 (2022).","journal-title":"Cancer Res."},{"issue":"7","key":"42545_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17070927","volume":"17","author":"S Alamos-Musre","year":"2025","unstructured":"Alamos-Musre, S. et al. From structure to function: The promise of PAMAM dendrimers in biomedical applications. Pharmaceutics 17(7), 927. https:\/\/doi.org\/10.3390\/pharmaceutics17070927 (2025).","journal-title":"Pharmaceutics"},{"issue":"20","key":"42545_CR50","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1039\/c9ra00834a","volume":"9","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy. RSC Adv. 9(20), 11026\u201311037. https:\/\/doi.org\/10.1039\/c9ra00834a (2019).","journal-title":"RSC Adv."},{"key":"42545_CR51","doi-asserted-by":"publisher","DOI":"10.1021\/acsanm.4c06257","author":"R Zhang","year":"2025","unstructured":"Zhang, R. et al. Tumor microenvironment-responsive MnOx-mesoporous carbon nanoparticles for enhanced chemodynamic synergistic antitumor therapy. ACS. Appl. Nano. Mater. https:\/\/doi.org\/10.1021\/acsanm.4c06257 (2025).","journal-title":"ACS. Appl. Nano. Mater."},{"issue":"3","key":"42545_CR52","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.7150\/thno.120283","volume":"16","author":"ZY Chen","year":"2026","unstructured":"Chen, Z. Y., Liu, H. Z., Shang, Z. J., Luo, G. F. & Zhang, X. Z. Nanomedicine for targeting cancer-associated fibroblasts in cancer therapy. Theranostics 16(3), 1545\u20131576. https:\/\/doi.org\/10.7150\/thno.120283 (2026).","journal-title":"Theranostics"},{"key":"42545_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","volume":"12","author":"F Abedi-Gaballu","year":"2018","unstructured":"Abedi-Gaballu, F. et al. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Appl. Mater. Today. 12, 177\u2013190. https:\/\/doi.org\/10.1016\/j.apmt.2018.05.002 (2018).","journal-title":"Appl. Mater. Today."},{"issue":"3","key":"42545_CR54","first-page":"217","volume":"67","author":"S Dash","year":"2010","unstructured":"Dash, S., Murthy, P. N., Nath, L. & Chowdhury, P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 67 (3), 217\u2013223 (2010).","journal-title":"Acta Pol. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42545-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42545-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42545-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:06:10Z","timestamp":1786579570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42545-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42545"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42545-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25238"}}